|
|
BioSerenTach is aggressively and globally looking for partners.
We actively look for partners which suffer from bioavailability problem
of API.
BioSerenTach codevelops suitable formulations for API with our DDS technologies. |
| BioSerenTach Inc. |
| Head office |
Azuchi-cho 618, Shimogyo-ku, Kyoto 600-8040, Japan |
| Tel |
075-361-2050 (from abroad 81-75-361-2050)
|
| Fax |
075-202-5529 (from abroad 81-75-202-5529) |
| Established |
August 1, 2001 |
| E-mail |
info@bioserentach.co.jp |
| Chairman |
Prof. Kanji Takada, Ph. D. |
| President |
Yasuyo Takada |
| Capitalization |
￥10,000,000 |
| Main Bank |
Kyoto Bank |
|
Copyright BioSerenTach Inc, 2009
|
|
